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SUMMARY
Second messengers are small molecules and ions that relay signals received by cell-surface
receptors to effector proteins. They include awide varietyof chemical species and have diverse
properties that allow them to signal within membranes (e.g., hydrophobic molecules such as
lipids and lipid derivatives), within the cytosol (e.g., polar molecules such as nucleotides and
ions), or between the two (e.g., gases and free radicals). Second messengers are typically
present at low concentrations in resting cells and can be rapidly produced or released when
cells are stimulated. The levels of secondmessengers are exquisitely controlled temporallyand
spatially, and, during signaling, enzymatic reactions or opening of ion channels ensure that
they are highly amplified. These messengers then diffuse rapidly from the source and bind
to target proteins to alter their properties (activity, localization, stability, etc.) to propagate
signaling.
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1 INTRODUCTION
Signals received by receptors at the cell surface or, in some
cases, within the cell are often relayed throughout the cell
via generation of small, rapidly diffusing molecules referred
to as second messengers. These second messengers broad-
cast the initial signal (the “first message”) that occurs when
a ligand binds to a specific cellular receptor (see Heldin
et al. 2014); ligand binding alters the protein conformation
of the receptor such that it stimulates nearby effector pro-
teins that catalyze the production or, in the case of ions,
release or influx of the second messenger. The second mes-
senger then diffuses rapidly to protein targets elsewhere
within the cell, altering the activities as a response to the
new information received by the receptor. Three classic
second messenger pathways are illustrated in Figure 1: (1)
activation of adenylyl cyclase by G-protein-coupled recep-
tors (GPCRs) to generate the cyclic nucleotide second mes-
senger 3′-5′-cyclic adenosine monophosphate (cAMP);
(2) stimulation of phosphoinositide 3-kinase (PI3K) by
growth factor receptors to generate the lipid second mes-
senger phosphatidylinositol 3,4,5-trisphosphate (PIP3);
and (3) activation of phospholipase C by GPCRs to gener-
ate the two second messengers membrane-bound messen-
ger diacylglycerol (DAG) and soluble messenger inositol
1,4,5-trisphosphate (IP3), which binds to receptors on sub-
cellular organelles to release calcium into the cytosol. The
activation of multiple effector pathways by a single plasma
membrane receptor and the production of multiple second
messengers by each effector can generate a high degree of
amplification in signal transduction, and stimulate diverse,
pleiotropic, responses depending on the cell type.
Second messengers fall into four major classes: cyclic
nucleotides, such as cAMP and other soluble molecules
that signal within the cytosol; lipid messengers that signal
within cell membranes; ions that signal within and between
cellular compartments; and gases and free radicals that can
signal throughout the cell and even to neighboring cells.
Second messengers from each of these classes bind to spe-
cific protein targets, altering their activity to relay down-
stream signals. In many cases, these targets are enzymes
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Figure 1. Second messengers disseminate information received from cell-surface receptors. Indicated are three
examples of a receptor activating an effector to produce a second messenger that modulates the activity of a target.
On the right, binding of agonists to a GPCR (the receptor) can activate adenylyl cyclase (the effector) to produce
cAMP (the second messenger) to activate protein kinase A (PKA; the target). On the left, binding of growth factors
to a receptor tyrosine kinase (RTK; the receptor) can activate PI3K (the effector) to generate PIP3 (the second
messenger), which activates Akt (the target). In the center, binding of ligands to a GPCR (receptor) activates
phospholipase C (PLC; the effector), to generate two second messengers, DAG and IP3, which activate protein
kinase C (PKC; the target) and release calcium from intracellular stores, respectively.
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whose catalytic activity is modified by direct binding of the
second messengers. The activation of multiple target en-
zymes by a single second messenger molecule further am-
plifies the signal.
Second messengers are not only produced in response
to extracellular stimuli, but also in response to stimuli from
within the cell. Moreover, their levels are exquisitely con-
trolled by various homeostatic mechanisms to ensure pre-
cision in cell signaling. Indeed, dysregulation of the second
messenger output in response to a particular agonist can
result in cell/organ dysfunction and disease. For example,
chronic exposure to cAMP in the heart results in an un-
controlled and asynchronous growth of cardiac muscle cells
called pathological hypertrophy. This early stage heart dis-
ease presents as a thickening of the heart muscle (myocar-
dium), a decrease in size of the chamber of the heart, and
changes in contractility. Because such prolonged exposure
to second messengers has deleterious effects, specific en-
zymes, channels, and buffering proteins exist to rapidly
remove second messengers, either by metabolizing them
or sequestering them away from target molecules.
2 CYCLIC NUCLEOTIDES
2.1 cAMP and a Major Target, PKA
The “fight or flight” mechanism, more accurately referred
to as the adrenal response, prepares the body for situations
of extreme stress. Release of the hormone epinephrine, also
known as adrenaline, from the adrenal gland into the blood
rapidly triggers vital cellular and physiological reactions
that prepare the body for intense physical activity. One of
the most important effects is the breakdown of glycogen
into glucose to fuel muscles (Sutherland 1972).
Earl Sutherland first showed that epinephrine bound
to cell-surface receptors stimulates membrane-associated
adenylyl cyclases to synthesize the chemical messenger
cAMP. Martin Rodbell and Alfred Gillman then discovered
that G-protein subunits are the intermediates that shuttle
between receptors and a family of eight adenylyl cyclase
isoforms in the plasma membrane. Each G protein is a
trimer consisting of Ga, Gb, and Gg subunits. The Ga
subunits in the G proteins Gs and Gi are distinct and pro-
vide the specificity for activation and inhibition of adenylyl
cyclase, respectively. Gs and Gi can thus couple binding
of ligands to GPCRs with either activation or inhibition
of adenylyl cyclase, depending on the receptor type. This
increases or reduces production of cAMP, which diffuses
from the membrane into the cell. Edwin Krebs and Ed-
mund Fischer later found that a principal task of cAMP
is to stimulate protein phosphorylation (Fischer and Krebs
1955), ultimately showing cAMP-dependent protein ki-
nase (also known as protein kinase A, PKA) is responsible
(Krebs 1993; Gilman 1995).
PKA is the major target for cAMP (see Fig. 2) (Sassone-
Corsi 2012). It is a heterotetramer consisting of two regu-
latory (R) subunits that maintain two catalytic (C) subunits
in an inhibited state. When cAMP levels are low, the PKA
holoenzyme is dormant; however, when cAMP levels are
elevated, two molecules bind in a highly cooperative man-
ner to each R subunit, causing a conformational change that
releases the active C subunits (Taylor et al. 2012). In hu-
mans, four genes encode R subunits (RIa, RIb, RIIa, and
RIIb) and two genes encode C subunits (Ca and Cb), com-
binations of which are expressed in most, if not all, tissues.
The C subunits of PKA phosphorylate serine or threonine
residues on target substrates, typically within the sequence
RRxS/TF, in which F is an aliphatic hydrophobic residue
or an aromatic residue (Kemp et al. 1976). Around 300–500
distinct intracellular proteins can be phosphorylated by
PKA in a typical cell. These include glycogen phosphorylase
as part of the fight-or-flight mechanism. Active phosphor-
ylase catalyzes the production of glucose 1-phosphate, a
metabolic intermediate that is ultimately converted into
other modified sugars that are used in various aspects of
cellular catabolism and ATP production (see Hardie 2012).
On its release from the PKA holoenzyme, the C subunit of
PKA can diffuse into the nucleus, where it phosphorylates
transcription factors such as the cAMP-response-element-
binding protein. cAMP can thereby ultimately influence
transcriptional activation and reprogramming of the cell.
Additional layers of regulation ensure that PKA phos-
phorylates the correct proteins at the right time. For ex-
ample, prostaglandin E1 and epinephrine both produce
similar increases in cAMP and PKA activity in the heart,
but only epinephrine increases glycogen phosphorylase ac-
tivity. This is achieved in part through attachment of PKA
to subcellular structures via interactions between R sub-
units and A-kinase-anchoring proteins (AKAPs) (Wong
and Scott 2004). Anchoring of PKA to subcellular struc-
tures by AKAPs is a means to limit the range of action of
PKA and avert the indiscriminate transmission of these
responses throughout the cell.
A typical cell expresses 10–15 different AKAPs. These
proteins all contain an amphipathic-helix motif that binds
to a docking and dimerization domain formed by the R
subunits of PKA and targeting domains that tether the
AKAPs to intracellular membranes or organelles. AKAPs
promote signaling efficacy by placing PKA near preferred
substrates and insulating different anchored PKA complex-
es from one another (Scott and Pawson 2009). Most AKAPs
also organize other signaling proteins, such as GPCRs,
GTPases, protein phosphatases, phosphodiesterase (PDE),
and other protein kinases.
Second Messengers
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Figure 2. (A) cAMP is the archetypical second messenger. Its levels increase rapidly following receptor-mediated
activation of adenylyl cyclase (AC), which catalyzes the conversion of adenosine monophosphate (AMP) to
cAMP. This small second messenger activates PKA at specific cellular locations as a result of anchoring of PKA to
A-kinase-anchoring proteins (AKAPs). In addition, cAMP activates EPACs. (B) AC activity is controlled by the
opposing actions of the Gs and Gi proteins. The cAMP produced by AC activates PKA by binding to its R
subunit. This releases the C subunit. The signal can be terminated by the action of phosphodiesterase (PDE)
enzymes.
A.C. Newton et al.
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2.2 3′-5′-Cyclic Guanosine Monophosphate
and cGMP-Dependent Protein Kinase
3′-5′-cyclic guanosine monophosphate (cGMP) is another
cyclic nucleotide that serves as a second messenger. cGMP
is often synthesized by receptor guanylyl cyclases, which
have their catalytic domains close to the inner face of the
plasma membrane and are stimulated by small peptide fac-
tors that bind to their extracellular domains. It can also be
produced by soluble cytoplasmic guanylyl cyclases, which
are stimulated by nitric oxide. This latter signaling path-
way is involved in a number of important physiological
processes, including smooth muscle relaxation and neuro-
transmission (see Heldin et al. 2014). cGMP targets cGMP-
dependent protein kinase (PKG), a dimeric enzyme that
has an R and C domain within the same polypeptide chain.
When cGMP levels are low, PKG is dormant; however, when
cGMP levels are elevated, two molecules bind to each R
domain in the dimer, exposing the active catalytic domains.
There are two PKG isozymes: the type I enzyme is soluble
and predominantly cytoplasmic, whereas the type II en-
zyme is particulate and is attached to a variety of biologi-
cal membranes. PKG phosphorylates peptide sites with
the general consensus—RRXS/TX. Hence, PKA and PKG
have overlapping substrate specificities. However, a major
difference is that PKG expression is restricted to the brain,
lungs, and vascular tissue, where this enzyme controls
important physiological processes, including the regulation
of smooth muscle relaxation, platelet function in the blood,
cell division, and aspects of nucleic acid synthesis. PKG
causes relaxation of vascular smooth-muscle cells, for ex-
ample, by phosphorylating several structural proteins that
are vital for this process.
2.3 Other cAMP and cGMP Targets
Other cAMP and cGMP targets also play key roles in cellu-
lar physiology. For example, cyclic nucleotide-gated chan-
nels (nonselective channels that allow many ions to flow
into or out of a cell) have important functions in retinal
photoreceptors and olfactory receptor neurons (see Julius
and Nathans 2012). Most notably, cGMP is a key second
messenger in vision: photoisomerization of the chromo-
phore in the light receptor, rhodopsin, produces a confor-
mational change in the receptor that allows it to activate
the G protein transducin, which, in turn, activates a cGMP
PDE. The resulting reduction in the concentration of
cGMP leads to the closure of sodium and calcium channels
and, thus, hyperpolarization of photoreceptor cells, leading
to changes in neurotransmitter release. Mutations in many
components of this pathway, including the PDE, cause
blindness. Regulation of ion channels by cAMP is particu-
larly important in the sinoatrial node of the heart, in which
cAMP-responsive hyperpolarization-activated cyclic nu-
cleotide-gated (HCNs) channels help to generate pacemak-
er currents that control cardiac contractility (see Kuo and
Ehrlich 2014). Other classes of HCN channel have analo-
gous functions in the brain and nervous system. cAMP
also controls the cAMP-responsive guanine nucleotide ex-
change factor EPAC1, a protein that promotes activation
of the Rap1 GTPase to regulate cell adhesion by stimulating
integrin molecules in the plasma membrane (Bos 2003).
2.4 Cyclic Nucleotide PDEs
Termination of cAMP and cGMP signals is mediated by
PDEs. These enzymes represent a vast gene family of 11
distinct subtypes and more than 100 isoforms that can
break the phosphoester bond of either cyclic nucleotide
to liberate AMP or GMP (Beavo and Brunton 2002). PDE
activity can be regulated in a variety of ways. For example,
calcium-dependent processes control the activity of the
PDE1 and PDE2 isoforms, PKA phosphorylation attenu-
ates the activity of PDE3 and PDE4 isoforms, and PKA or
PKG phosphorylation participates in the control of PDE5.
Less is known about the mechanisms of regulation for
PDE6-11. More recently, there has been considerable inter-
est in the development and clinical application of small-
molecule PDE inhibitors. Selective PDE inhibitors that
produce elevated levels of cAMP/cGMP have been used
clinically to alleviate chronic obstructive pulmonary dis-
ease, asthma, and combat certain immune disorders, but
their most celebrated therapeutic application has been
in the treatment of male erectile dysfunction. Sildenafil
citrate (Viagra) and its relatives act by inhibiting cGMP-
specific PDE5 (Beavo and Brunton 2002) in the arterial
wall smooth muscle of the penis, which elevates cGMP
and increases blood flow.
3 LIPID AND LIPID-DERIVED SECOND
MESSENGERS
Two seemingly unrelated discoveries half a century ago
provided the first insights into how cells use lipids to signal.
Hokin and Hokin discovered that cholinergic stimulation
of pancreatic slices promotes incorporation of 32P from
radiolabeled ATP into phospholipids, which led to an ex-
plosion of studies showing that numerous extracellular sig-
nals promote hydrolysis of phosphoinositides in cells and
eventually the identification of DAG as a major second
messenger. During this period, Yasutomi Nishizuka puri-
fied the enzyme PKC and showed it is the target for this
lipid second messenger (Nishizuka 1992).
We now know that many extracellular signals trigger
hydrolysis of two classes of lipids to generate second mes-
Second Messengers
Advanced Online Article. Cite this article as Cold Spring Harb Perspect Biol doi: 10.1101/cshperspect.a005926 5
Harbor Laboratory Press 
 at SERIALS/BIOMED LIB0175B on August 1, 2016 - Published by Cold Springhttp://cshperspectives.cshlp.org/Downloaded from 
sengers: glycerolipids, whose hydrophobic backbone is
DAG (e.g., phosphatidylinositol 4,5-bisphosphate, PIP2),
and sphingolipids, whose hydrophobic backbone is cer-
amide (e.g., sphingomyelin). Both produce a variety of
products that are involved in cell signaling (Fig. 3). Binding
of ligands to receptors that couple to lipid-modifying en-
zymes (see below) results in activation of enzymes that
hydrolyze specific acyl chains or polar head groups from
each lipid class to generate lipid second messengers. Spe-
cifically, hydrolysis of acyl chains generates lysophospholi-
pids (e.g., lysophosphatidylcholine and lysophosphatidic
acid through hydrolysis catalyzed by phospholipase A2)
and lysophingolipids (e.g., sphingosine through hydrolysis
catalyzed by ceramidases). It also produces free fatty acids,
such as arachidonic acid, which are important signaling
entities in their own right.
Hydrolysis of polar head groups from glycerophos-
pholipids by phospholipase D and PLC results in genera-
tion of phosphatidic acid and DAG, respectively. The polar
head group released following PIP2 hydrolysis, IP3, is a
key second messenger itself. IP3 can also be further phos-
phorylated to form polyphosphoinositols that serve as
additional second messengers. Hydrolysis of the polar
head group from sphingomyelin, catalyzed by sphingomye-
linase, produces ceramide. Further hydrolysis of the acyl
chain by ceramidase produces sphingosine, and the subse-
quent phosphorylation of this by sphingosine kinase pro-
duces sphingosine 1-phosphate.
Lipid second messengers that retain two acyl chains
(e.g., phosphatidic acid, DAG, and ceramide) remain mem-
brane associated, but the decreased lipophilicity of second
messengers that retain only one acyl chain (lysolipids such
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Figure 3. Lipid-derived second messengers. (A) Hydrolysis of glycerophospholipids results in the production of
lysophospholipids, free fatty acids (arachidonic acid is shown), diacylglycerol, phosphatidic acid, and, in the case of
hydrolysis of PIP2, the water soluble inositol 3,4,5-trisphosphate. (B) Hydrolysis of sphingolipids yields ceramide,
sphingosine, and sphingosine 1-phosphate.
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as lysophosphatidic acid and sphingosine) allows them to
dissociate from membranes and serve as soluble second
messengers. Finally, note that in addition to its hydrolysis,
PIP2 can be phosphorylated to produce another key second
messenger, PIP3 (see below).
3.1 IP3 and DAG
Signals from both GPCRs (e.g., histamine receptors) and
RTKs (e.g., epidermal growth factor [EGF] receptors) can
result in activation of PLC, which cleaves phospholipids to
generate DAG and IP3. In the case of GPCR signaling, lipid
hydrolysis is mediated by binding of G proteins (notably
Gq) to phospholipases (PLCb); in the case of RTKs, lipid
hydrolysis is mediated by recruitment of phospholipases
(PLCg) to tyrosine-phosphorylated proteins at the plasma
membrane (tyrosine phosphorylation of PLCg by RTKs
also stimulates its activity directly). If the lipid cleaved is
PIP2 (rather than phosphatidylcholine [PC]), then water-
soluble IP3 is also produced. IP3 binds to IP3 receptors on
the endoplasmic reticulum (ER), and other organelles,
causing release of calcium into the cytosol (Fig. 1). It can
be further modified to yield additionally phosphorylated
phosphoinositols, including diphosphoryl inositol phos-
phates (Tsui and York 2010). Inositol 1,3,4,5-tetrakisphos-
phate (IP4) activates chloride channels. Inositol 1,2,3,4,5,6-
hexaphosphate (IP6) is a compound found in plants
(hence, its name phytic acid), but it is also present in yeast
and animal cells, along with the enzymes that synthesize
and metabolize it, and is gaining interest as a potential
anticancer agent because of its apoptosis-promoting prop-
erties. The DAG sensor is a small globular domain, called
the C1 domain, originally identified in PKC. Approximate-
ly 30 other proteins contain a C1 domain (Colon-Gonzalez
and Kazanietz 2006), including protein kinase D, Ras, gas-
trin-releasing polypeptides, DAG kinase, and n-chimaerin.
PKC represents a family of nine genes grouped into
three families (Newton 2009). The so-called conventional
PKC isozymes require the coordinated presence of both
calcium (sensed by the C2 domain) and DAG (sensed by
the adjacent C1 domain) for activation and thus transduce
signals that trigger PIP2 hydrolysis, but not those that trig-
ger hydrolysis of other phospholipids, such as PC (because
these do not mobilize calcium via IP3). Novel isozymes of
PKC do not have a calcium sensor, but because they bind
DAG with an affinity two orders of magnitude higher than
conventional PKC isozymes, they are efficiently activated
by DAG alone. Thus, they can transduce signals triggered
by PC hydrolysis. A third class of PKC isozymes, the atyp-
ical PKCs, do not respond to DAG or calcium. Signaling by
conventional and novel PKC isozymes is terminated by
phosphorylation of DAG by DAG kinase, which removes
the second messenger. Note that PKC isozymes are consti-
tutively phosphorylated but, unlike many other kinases,
these phosphorylations do not acutely regulate activity.
DAG- or calcium-dependent translocation of conven-
tional and novel PKC isozymes to the membrane is a hall-
mark of their activation (see Fig. 4). In unstimulated cells,
PKC localizes to the cytosol, where it may be concentrated
on specific protein scaffolds. For example, the conventional
PKCa binds to the PDZ-domain scaffold DLG1. PIP2 hy-
drolysis provides calcium, which binds to the C2 domain
and thus recruits cytosolic PKC to the plasma membrane;
there, PKC binds to the membrane-embedded second mes-
senger DAG via its C1 domain. Binding of both the C2 and
C1 domains to membranes provides the energy to release
an autoinhibitory pseudosubstrate segment from the sub-
strate-binding cavity, allowing PKC to phosphorylate sub-
strates and relay signals. Interestingly, a function common
to many of the PKC isozymes is that their phosphorylation
of certain substrates terminates signaling pathways. For
example, phosphorylation of receptors such as the EGF
and insulin receptors by PKC promotes their internaliza-
tion and degradation, thus acting as a negative feedback
loop to attenuate signaling via these pathways.
PKC has a unique signature of activation depending on
its cellular location (Gallegos and Newton 2008). In gen-
eral, its activation kinetics mirror those for the increase in
intracellular calcium concentration, and deactivation ki-
netics mirror the decay of DAG. Thus, membranes such
as the Golgi in which DAG production is sustained serve
as a platform for sustained PKC activity, whereas mem-
branes such as the plasma membrane where DAG is more
rapidly removed by phosphorylation serve as platforms for
transient PKC activity. Although PKC can phosphorylate
cytosolic targets, these events likely occur at the membrane.
Reduction in cytoplasmic calcium levels and phosphoryla-
tion of DAG by DAG kinase effectively terminates PKC
signaling.
3.2 PIP3 and Akt Signaling
Binding of growth factors to receptor tyrosine kinases re-
sults in the activation of PI3K isoforms (Fig. 4B), which
catalyze the phosphorylation of PIP2 at the 3
′ position
to generate the very minor, but highly efficacious, lipid
second messenger PIP3 in the plasma membrane (Cantley
2002). PI3K also phosphorylates phosphatidylinositol and
phosphatidylinositol 4-phosphate (PIP) at the 3′ position
to generate corresponding 3′-phosphoinositides that also
serve as second messengers. PIP2 is itself a minor compo-
nent of the plasma membrane, accounting for 0.05% of
the total phospholipid, yet the phosphorylation of 10%
of this pool effectively transduces growth factor signals.
Second Messengers
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The reason for this highly effective signaling is the use
of protein modules that bind with high affinity and specif-
icity to the various phosphorylated species of the inositol
head group (e.g., inositol 3,4,5-trisphosphate versus inosi-
tol 3,4-bisphosphate) that is exposed to the cytosol. These
include pleckstrin homology (PH), FYVE, and PB domains
(Lemmon 2007; Hemmings and Restuccia 2012).
The best defined target for PIP3 is the prosurvival ki-
nase Akt (Manning and Cantley 2007). Like PKC, Akt is
present in the cytosol in unstimulated cells. PIP3 produced
following PI3K activation recruits Akt to the plasma mem-
brane via its PH domain. This triggers the phosphoryla-
tion of Akt at two sites, leading to its activation and
downstream signaling. The first phosphorylation is cata-
lyzed by the phosphoinositide kinase PDK1 (also recruited
to the membrane by PIP3) at a segment near the entrance
to the active site, which, in turn, leads to rapid phosphor-
ylation at a carboxy-terminal site. Autophosphorylation
Growth
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Ras Akt
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PI3K
PIP3
IRS
PTEN
PIP2 PIP3
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Target substrates
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B
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Figure 4. (A) PKC transduces signals that promote phospholipid hydrolysis. Signals that cause phospholipase-C-
mediated hydrolysis of PIP2 activate conventional PKC isozymes by a two-step mechanism. First, calcium (whose
levels increase following IP3 production) binds to the C2 domain of PKC. This increases the affinity of the module for
the plasma membrane, causing PKC to translocate to the membrane. Here, it binds its allosteric activator, DAG. This
binding produces a conformational change that expels the autoinhibitory pseudosubstrate segment from the active
site, allowing substrate phosphorylation and downstream signaling. (B) Activation of PI3K following engagement of
growth factor receptors such as insulin receptor generates the phospholipid PIP3, which recruits the kinases PDK1
and Akt to the membrane. Subsequent phosphorylation events lead to activation of Akt.
A.C. Newton et al.
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and the mTORC2 kinase complex have been proposed
to regulate this second site (see Laplante and Sabatini
2012). Once phosphorylated, Akt is locked in an active
and signaling-competent conformation and can be re-
leased from the plasma membrane to signal throughout
the cell, including the nucleus. Signaling is terminated
by dephosphorylation of PIP3 and dephosphorylation of
Akt. The former is catalyzed by the tumor suppressor
PTEN, a lipid phosphatase, which removes the lipid
second messenger by dephosphorylating the 3′ phosphate
of PIP3. Dephosphorylation of the two Akt sites is catalyzed
by protein phosphatases such as the tumor suppressor
PHLPP.
3.3 Sphingolipid Hydrolysis and Protein Targets
that Control Apoptosis
Sphingolipids are a class of bioactive lipids that play im-
portant roles in diverse cellular responses (Hannun and
Obeid 2008). The major signaling lipids derived from
sphingomyelin are ceramide, sphingosine, and sphingosine
1-phosphate, which are produced by the action of sphin-
gomyelinase, ceramidase, and sphingosine kinase, respec-
tively (Fig. 3).
Ceramide propagates information in stress-response
pathways; it is produced following activation of receptors
by stimuli such as cytokines or death ligands and also by
nonreceptor signals in response to radiation, cytotoxic in-
sult, or infection by pathogens. Sphingosine also has apo-
ptotic roles, although its direct targets in cells are unclear.
In contrast to ceramide and sphingosine, sphingosine 1-
phosphate promotes prosurvival signaling. When secreted,
it binds to a class of GPCRs that promote diverse cellular
effects, including cell-survival, differentiation, inflamma-
tion, and angiogenesis (Pitson 2011). Intracellular sphin-
gosine 1-phosphate acts as a second messenger, activating
enzymes such as the TRAF2 E3 ligase and some histone
deacetylases.
3.4 Lysolipids, Prostaglandins, and Other
Eicosanoids
Oxidation of 20-carbon fatty acids produces eicosanoids,
thus signaling molecules that bind to GPCRs to mediate
inflammatory and immune responses (Wymann and
Schneiter 2008). Phospholipase-A2-mediated hydrolysis
of phospholipids containing arachidonic acid (a 20-carbon
unsaturated fatty acid) in the sn-2 position of the glycerol
backbone (see Fig. 3) yields a fatty-acid product that can
be oxidized by cyclooxygenases to yield prostaglandins, or
by lipooxygenases to yield leukotrienes. These signaling
molecules bind to specific receptors that couple to diverse
pathways. Many of these are involved in inflammatory re-
sponses. Notably, leukotrienes bind to GPCRs that cause
inflammatory responses common in asthma, and, as such,
leukotriene pathways serve as targets for antiasthma drugs.
Aspirin inhibits cyclooxygenases and thus the production
of prostaglandins, which are inflammatory (Venteclef et al.
2011). As mentioned above, arachidonic acid itself also
serves as a second messenger.
4 IONS AS INTRACELLULAR MESSENGERS
Ions such as sodium, potassium, calcium, magnesium,
protons, chloride, iron, and copper play essential roles in
cell function. Many ions act as cofactors for structural
proteins and enzymes. Moreover, cellular processes are
sensitive to changes in their ambient ionic environment;
changes in pH, for example, can alter enzymatic activity
and the behavior of cellular ion transporters (Vaughan-
Jones et al. 2009). In addition, ions control cellular activity
by spreading electrical signals, for example, action poten-
tials in heart and neurons.
Ions such as calcium and magnesium can also play
direct roles as dynamic intracellular messengers that regu-
late specific protein targets during signal transduction (Fig.
5A). These ions are imported from the extracellular milieu
or mobilized from intracellular stores and control the activ-
ity of protein targets by binding to specific motifs on the
protein itself or upstream regulators (e.g., calmodulin)
(Berridge et al. 2000). Note that most ions should not be
considered intracellular messengers, however. For example,
the sodium ions that enter cardiac myocytes during an
action potential serve only to depolarize the cell mem-
brane. This causes the opening of voltage-operated calcium
channels (VOCCs), allowing influx of the real messenger—
calcium ions—which control contraction by binding to
proteins such as calmodulin and troponin C (Kuo and
Ehrlich 2014). Similarly, to reverse an action potential,
potassium ions are rapidly extruded and the membrane
potential is restored, but it is the reversion of the calcium
concentration to the prestimulated state through the action
of the sodium/calcium exchanger (NCX) that represents
signal termination (sodium and potassium levels are re-
turned to the original state by the sodium/potassium
ATPase [Na+/K+-ATPase], so that another action potential
can be evoked).
A key reason for using ions as messengers is speed of
response. Cells use energy to maintain gradients of ions
across their lipid membranes. By activating channels or
transporters, cells can use the potential energy established
by the electrochemical gradient of an ion to rapidly gener-
ate a cellular signal (Clapham 2007). Unlike other intra-
cellular messengers, ionic signals can be generated with no
enzymatic steps. The speed of the response depends on the
Second Messengers
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Figure 5. (A) Calcium and magnesium signals. Both ions can enter cells via channels in the plasma membrane. In
addition, calcium is stored in organelles such as the ER. Calcium exerts its effects by binding to numerous cellular
protein targets, including calmodulin, whereas magnesium may function as a calcium mimetic or have magnesium-
specific effects. (B) The various ways in which calmodulin can function to alter cellular targets. It is generally thought
that cellular calmodulin is largely bound to proteins even when the calcium concentration is low, and that there is a
relatively small pool of cytosolic calcium-free calmodulin (apocalmodulin). However, even apocalmodulin can
regulate specific cellular processes (e.g., IP3 receptors, IP3Rs). When the calcium concentration is elevated, calcium
ions bind to calmodulin. This causes calmodulin to be displaced from some targets and associate with others. In
some cases (e.g., phosphorylase kinase), calmodulin is a constitutively bound subunit that binds calcium and
activates the enzyme when the calcium concentration is elevated. Other calcium-binding proteins, such as neuronal
calcium sensors, may also display complex interactions with their various targets. ∗CaM-dependent inhibition of
IP3R channels.
Harbor Laboratory Press 
 at SERIALS/BIOMED LIB0175B on August 1, 2016 - Published by Cold Springhttp://cshperspectives.cshlp.org/Downloaded from 
rate at which the intracellular concentration of the ion
changes and the proximity of the ions to their cellular tar-
gets. For example, action potentials cause the fast release of
neurotransmitters at nerve terminals because the cytosolic
concentration of calcium ions just beneath the plasma
membrane increases from 100 nM to .10 mM within
milliseconds (Berridge 2006). In situations in which ions
have to diffuse further before encountering their target(s),
the response will be slower. As we discuss below, the ability
to generate different spatiotemporal patterns, such as waves
and oscillations, is another important advantage of ionic
intracellular messengers.
4.1 Calcium
Calcium is an extremely versatile intracellular messenger
that controls a wide range of cellular functions by regu-
lating the activity of a vast number of target proteins. The
cellular effects of calcium are mediated either by direct
binding to a target protein, or stimulation of calcium
sensors that detect changes in calcium concentration and
then activate different downstream responses (Berridge
2004). The multitude of sensors that mediate effects of
calcium can be characterized by the nature of their calci-
um-binding site(s). The most common calcium-binding
motifs are EF-hands and C2 domains. Synaptotagmin
and troponin C are examples of proteins with C2 domains
and EF-hands, respectively. Calcium sensors also act by
recruiting a range of intermediary effectors, such as cal-
cium-sensitive enzymes—for example, calcium/calmodu-
lin-dependent protein kinases (CaMKs), calcineurin (also
known as protein phosphatase 2B), myosin light chain
kinase, and phosphorylase kinase (see Kuo and Ehrlich
2014).
4.2 Control of Calcium Levels
Intracellular calcium levels are controlled by an assort-
ment of channels, pumps, transporters, buffers, and effec-
tor moieties. At rest, cytosolic calcium is maintained at
100 nM. In most cases, its levels are elevated by the open-
ing of channels located either on various organellar stores
or in the plasma membrane. Release of calcium from in-
ternal stores represents a major source of signal calcium for
many cells. The principal calcium stores are the ER, sarco-
plasmic reticulum (SR), Golgi, and acidic organelles of the
endolysosomal system (Bootman et al. 2002). Calcium re-
lease channels are present on the membranes of these or-
ganelles and gate the flux of calcium from the ER/SR
lumen into the cytosol. Ubiquitous calcium-release chan-
nels include the IP3Rs that respond to IP3 produced by
hydrolysis of PIP2 (Parys and De Smedt 2012), ryanodine
receptors (Belevych et al. 2013), and two-pore channels
that respond to nicotinic acid adenine dinucleotide phos-
phate (Galione 2011).
Channels that permit the influx of calcium across the
plasma membrane are typically characterized by their
activation mechanism. Receptor-operated calcium chan-
nels and second messenger-operated calcium channels are
opened by the binding of an external or internal ligand.
Examples of these are N-methyl-D-aspartate (NMDA) re-
ceptors that respond to the neurotransmitter glutamate
(see Kennedy 2013), and Orai channels regulated by the
intracellular messenger arachidonic acid. VOCCs that are
activated by a change in membrane potential are widely
expressed in excitable tissues and can be divided into three
families [CaV1 (L-type), CaV2 (N, P/Q, and R type), and
CaV3 (T type)], which have specific characteristics and
functions (Catterall 2011). The transient receptor potential
(TRP) family includes a number of calcium-permeable
channels with distinct activation mechanisms (Gees et al.
2012). Depletion of ER or SR calcium activates “store-op-
erated” calcium entry. This pathway for calcium influx has
been known for more than two decades, and the store-op-
erated current (Icrac, for calcium-release-activated current)
has beenwell characterized. However, the molecular players,
STIM (stromal interaction molecule) and Orai, have only
been identified relatively recently through investigation of
patients with severe combined immunodeficiency caused
by a lack of calcium influx into their T lymphocytes (Hogan
et al. 2010).
4.3 Calcium Buffers
Cells express a number of calcium-binding proteins that
buffer calcium changes within various cellular compart-
ments and modulate calcium signals. The rapid binding
of calcium by the cytosolic buffers parvalbumin and cal-
bindin D-28k shapes both the spatial and temporal prop-
erties of intracellular calcium signals (Schwaller 2010). ER/
SR calcium-binding proteins (e.g., calsequestrin, calreti-
culin, GRP78, and GRP94) facilitate the accumulation of
large amounts of calcium, which is necessary for rapid cell
signaling (Prins and Michalak 2011). Mitochondria also
play a key buffering role in that they express a calcium
uniporter capable of taking up substantial amounts of
calcium whenever the cytosolic calcium concentration in-
creases during signaling (Rizzuto and Pozzan 2006). The
uptake of calcium into the mitochondrial matrix stimulates
the citric acid cycle to produce more ATP. This increased
oxidation also enhances mitochondrial reactive oxygen
species (ROS) formation, which contributes to redox sig-
naling pathways. Loading of calcium into mitochondria is
believed to be essential to avoid induction of autophagy.
Second Messengers
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However, exaggerated mitochondrial calcium loading can
precipitate apoptosis (Baumgartner et al. 2009).
4.4 Signal Termination
Calcium pumps and exchangers are responsible for pump-
ing calcium out of the cell or back into the ER/SR to
terminate a calcium signal. These pumps and exchangers
operate at different times during the recovery process. NCX
proteins have low affinities for calcium, but have high ca-
pacities that enable them to rapidly remove large quantities
of calcium and are especially evident in excitable cells (Ni-
coll et al. 2013). The plasma membrane calcium-ATPase
and SR/ER calcium-ATPase enzymes have lower transport
rates but higher affinities, which means that they operate at
relatively low cytosolic calcium concentrations (Vande-
caetsbeek et al. 2011). Calcium/hydrogen exchangers are
important for the loading of calcium into endo/lysosomal
compartments.
4.5 Spatiotemporal Organization of the Calcium
Signaling Machinery
The substantial diversity of cellular calcium signals in dif-
ferent cell types reflects their use of distinct combinations
and arrangements of calcium-transport mechanisms. In
neurons, for example, microscopic calcium signals trigger
the release of neurotransmitter-containing vesicles at pre-
synaptic terminals (Berridge 2014). The calcium signal is
a plume of ions around the mouth of an open channel
that dissipates within milliseconds and can only activate
processes within a few tens of nanometers. The receiver
for the calcium signal is synaptotagmin, a calcium-binding
protein that promotes fusion of the neurotransmitter-
containing vesicle with the neuronal plasma membrane.
The rapidity of this response depends on the calcium chan-
nels and exocytotic machinery (SNARE complexes) being
linked together within a highly localized microdomain.
A key component of the SNARE complex is SNAP-25,
a membrane-bound protein that interacts with both the
VOCCs and synaptotagmin. In contrast, the regular beating
of the heart relies on the sequential elevation of calcium
levels within all the myocytes of the atrial and ventricular
chambers. In this case, the calcium signal is global, occur-
ring across the whole volume of each myocyte to evenly
activate troponin C, thereby allowing actin and myosin to
engage and cause contraction (Kuo and Ehrlich 2014).
An important driver for global calcium signaling is
regenerative calcium elevation—that is, the autocatalytic
increase in cellularcalcium concentration. Regenerative cal-
cium signals arise because several components of the cal-
cium signaling toolkit, such as PLC, RYRs, and IP3Rs, are
activated by calcium (Roderick et al. 2003). The opening
of one calcium channel can therefore promote a positive
feed-forward reaction in which more calcium ions enter the
cytosol. This regenerative calcium-induced calcium release
(CICR) process can override cellular calcium buffers, en-
abling rapid coordinated surges in calcium concentration.
The triggering of CICR is typically the critical event in caus-
ing the transition from local to global calcium signaling.
Without CICR, the global calcium signals in cardiac myo-
cytes that trigger contraction (described above) would not
occur. CICR leads to a rapid increase in calcium concentra-
tion. Within an individual cell, each spike of calcium caused
by CICR is evident as calcium waves, such as the calcium
waves evoked by fertilization of an oocyte (see Wakai et al.
2011). Microscopic analysis and modeling has shown that
such waves propagate in a salutatory manner, involving
successive rounds of CICR and diffusion, as the wave jumps
from a cluster of calcium channels to the next (Thul et al.
2012). Such waves can engulf the entirety of the cellular
cytoplasm, and pervade into the nucleus to activate or in-
hibit transcription (Bootman et al. 2009).
If a cellular stimulus is not sufficient to trigger a global
response, then only local calcium elevations will occur. The
calcium ions emanating from channels during local calci-
um signaling only switch on processes within their imme-
diate vicinity. The sphere of action of such microdomains
depends on how long the channels are open, their ability to
conduct calcium, and the capacity of surrounding calcium
buffers and homeostatic mechanisms that remove calcium
(Parekh 2008). Calcium buffers and pumps are highly ef-
fective at restricting the diffusion of calcium so that the
calcium concentration declines exponentially with distance
from a calcium source. If local calcium events do not turn
into global calcium signals, the proximity of particular
effectors and their affinity for calcium determines the re-
sponse. For example, relatively low-affinity effector mole-
cules such as synaptotagmin (described above) and BK
potassium channels (big calcium-activated potassium
channels, also called maxi-K channels) depend on submi-
crometer proximity to a channel to sense an activating
calcium concentration. Sensor proteins with relatively
higher affinity, such as calmodulin and SK potassium chan-
nels (small calcium-activated potassium channels), can be
activated at greater distances.
4.6 Magnesium
Magnesium can also be considered an intracellular mes-
senger because its concentration can change dynamically in
response to cellular stimulation (Li et al. 2011). Given that
magnesium binds to nucleotides, oligonucleotides, and
hundreds of enzymes, it is reasonable to conclude that it
is an intracellular messenger in its own right. Of its poten-
A.C. Newton et al.
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tial binding sites, ATP is particularly important. Cellular
processes typically use ATP complexed with magnesium
as an energy source. Moreover, magnesium has been shown
to cause prolonged inhibition of potassium channels in
neurons following muscarinic acetylcholine receptor acti-
vation (an effect that is not mimicked by calcium), thereby
regulating neuronal excitability (Chuang et al. 1997).
In addition, magnesium deserves consideration be-
cause it influences the effects of calcium. Indeed, magne-
sium and calcium are typically thought to have antagonistic
actions. Magnesium frequently inhibits the transport and
cellular activities of calcium and can prevent pathological
consequences of increases in calcium levels (Romani
2013). Like calcium, there is an electrochemical gradient
of magnesium across the plasma membrane that can serve
as a reservoir for signal generation. The extracellular con-
centrations of magnesium and calcium are similar (1.1–
1.5 mM), and magnesium can also act as a “calcimimetic”
(e.g., by binding to the calcium-sensing receptor), a GPCR
that has pleiotropic actions. Within cells, the magnesium
concentration (0.3–1.5 mM) is several orders of magni-
tude higher than that of calcium. It has been suggested
that mitochondria might serve as a store of magnesium
and that magnesium can potentially regulate cellular res-
piration (Wolf and Trapani 2012). Moreover, magnesium
in the mitochondrial matrix inhibits permeability transi-
tion pore (PTP) activation, an increase in the leakiness
of the inner mitochondrial membrane that allows sol-
utes ,1500 Da to pass, and can precipitate mitochondrial
swelling, apoptosis, and cell death. Calcium promotes PTP,
so magnesium acts as a counteracting antagonist.
Like calcium, magnesium has a plethora of transport
pathways. Of these, TRPM6 and TRPM7 (members of the
TRP family) are relatively well understood. TRPM6 is re-
stricted to kidney tubules and the intestinal epithelium,
and plays an important role in magnesium (re)adsorption
(defective TRPM6 function leads to hypomagnesemia),
whereas TRPM7 is ubiquitously expressed in mammals.
Both TRPM6 and TRPM7 are “chanzymes”: ion channels
that incorporate a kinase domain. Interestingly, TRPM7 is
regulated by PIP2, the source of the calcium-mobilizing
messenger IP3. Moreover, it binds to PLC, the enzyme
that hydrolyses PIP2. Consequently, hormonal stimulation
of cells will lead to both a calcium signal (via IP3 produc-
tion) and a change in magnesium flux (via loss of PIP2-
mediated regulation of TRPM7) (Langeslag et al. 2007).
MagT1 is also believed to be a key cellular magnesium
channel. Like TRPM6 and TRPM7, it is located on the
plasma membrane of mammalian cells. However, whereas
TRPM6 and TRPM7 allow both calcium and magnesium
fluxes, it is believed that MagT1 is a specific pathway for
magnesium. Individuals bearing mutations in the MAGT1
gene show high levels of Epstein–Barr virus infection and
a predisposition to lymphoma (Chaigne-Delalande et al.
2013).
5 CONCLUDING REMARKS
Second messengers disseminate information received by
cellular receptors rapidly, faithfully, and efficaciously.
They are small, nonprotein organic molecules or ions that
bind to specific target proteins, altering their activities in
a variety of ways that allow them to respond appropriately
to the information received by receptors.
A key advantage of second messengers over proteins
is that, unlike proteins, second messenger levels are con-
trolled with rapid kinetics. Thus, whereas it may take tens
of minutes for the levels of a protein to increase signifi-
cantly, most second messenger levels increase within mi-
croseconds (e.g., ions) to seconds (e.g., DAG), They are
often produced from precursors that are abundant in cells
or released from stores that contain high concentrations of
the second messenger; so, their generation is not rate lim-
iting. Thus, when the appropriate signal is received, second
messengers are rapidly generated, diffuse rapidly, and alter
target protein function highly efficiently.
Second messengers vary significantly in size and chem-
ical character: from ions to hydrophilic molecules such as
cyclic nucleotides to hydrophobic molecules such as di-
acylglycerol. Moreover, the continuing discovery of new
second messengers is expanding the repertoire of molecules
known to convey information within the cell. Indeed, only
very recently, cyclic guanosine monophosphate-adenosine
monophosphate was shown to be a second messenger that
is synthesized by the enzyme cGAS in response to HIV
infection and binds to and activates a protein called STING,
leading to induction of interferon (Wu et al. 2013). The
ability to respond rapidly to information thus depends on
an expanding library of small molecules.
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